<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82766</article-id><article-id pub-id-type="doi">10.7554/eLife.82766</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Post-phagocytosis activation of NLRP3 inflammasome by two novel T6SS effectors</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-289819"><name><surname>Cohen</surname><given-names>Hadar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289820"><name><surname>Baram</surname><given-names>Noam</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289821"><name><surname>Fridman</surname><given-names>Chaya Mushka</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289822"><name><surname>Edry-Botzer</surname><given-names>Liat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-266979"><name><surname>Salomon</surname><given-names>Dor</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2009-9453</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-289823"><name><surname>Gerlic</surname><given-names>Motti</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9518-1833</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Clinical Microbiology and Immunology</institution>, <institution>Tel Aviv University</institution>, <addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line>, <country>Israel</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-44396"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Reviewing editor</role><aff><institution>Yale University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dorsalomon@mail.tau.ac.il</email> (DS);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>mgerlic@tauex.tau.ac.il</email> (MG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>09</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e82766</elocation-id><history><date date-type="received"><day>17</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>24</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Cohen et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Cohen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82766-v1.pdf"/><abstract><p>The type VI secretion system (T6SS) is used by bacteria to deliver toxic effectors directly into target cells. Most T6SSs mediate antibacterial activities, whereas the potential anti-eukaryotic role of T6SS remains understudied. Here, we found a <italic>Vibrio</italic> T6SS that delivers two novel effectors into mammalian host immune cells. We showed that these effectors induce a pyroptotic cell death in a phagocytosis-dependent manner; we identified the NLRP3 inflammasome as being the underlying mechanism leading to the T6SS-induced pyroptosis. Moreover, we identified a compensatory T6SS-induced pathway that is activated upon inhibition of the canonical pyroptosis pathway. Genetic analyses revealed possible horizontal spread of this T6SS and its anti-eukaryotic effectors into emerging pathogens in the marine environment. Our findings reveal novel T6SS effectors that activate the host inflammasome and possibly contribute to virulence and to the emergence of bacterial pathogens.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>2174/22</award-id><principal-award-recipient><name><surname>Salomon</surname><given-names>Dor</given-names></name><name><surname>Gerlic</surname><given-names>Motti</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>920/17</award-id><principal-award-recipient><name><surname>Salomon</surname><given-names>Dor</given-names></name><name><surname>Gerlic</surname><given-names>Motti</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Tel Aviv University Recanati</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Salomon</surname><given-names>Dor</given-names></name><name><surname>Gerlic</surname><given-names>Motti</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100019521</institution-id><institution>Clore Israel Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fridman</surname><given-names>Chaya Mushka</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Manna Center Program, Tel Aviv University</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fridman</surname><given-names>Chaya Mushka</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of Tel Aviv University. The protocol was approved by the Committee on the Ethics of Animal Experiments of  Tel Aviv University (Permit Number: 01-20-072).Experiments were performed according to the guidelines of the Institute's Animal Ethics Committees.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file</p></sec><supplementary-material><ext-link xlink:href="elife-82766-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>